Skip to main content

Table 1 Epidemiological and clinical characteristic of the MS patients and the healthy donors

From: Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the α7 nicotinic acetylcholine receptor GAT107

 

Healthy donors

MS patients

n

24

32

Female/male

19/5

23/9

Age (mean ± SE)

36.4 ± 3.2

40.1 ± 2.5

Disease duration (mean ± SE)

--

7.4 ± 1.1

EDSS (mean ± SE)

--

2.2 ± 0.3